ACADIA HEALTHCARE CO INC (ACHC) Fundamental Analysis & Valuation

NASDAQ:ACHC • US00404A1097

Current stock price

23.52 USD
-0.62 (-2.59%)
At close:
23.37 USD
-0.15 (-0.64%)
After Hours:

This ACHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ACHC Profitability Analysis

1.1 Basic Checks

  • ACHC had positive earnings in the past year.
  • In the past year ACHC had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
  • In the past 5 years ACHC always reported a positive cash flow from operatings.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of ACHC (-19.95%) is worse than 80.20% of its industry peers.
  • ACHC's Return On Equity of -56.58% is on the low side compared to the rest of the industry. ACHC is outperformed by 72.28% of its industry peers.
  • With a decent Return On Invested Capital value of 6.00%, ACHC is doing good in the industry, outperforming 61.39% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 8.98%.
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROIC 6%
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • ACHC's Operating Margin of 11.71% is amongst the best of the industry. ACHC outperforms 83.17% of its industry peers.
  • ACHC's Operating Margin has declined in the last couple of years.
  • ACHC does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 11.71%
PM (TTM) N/A
GM N/A
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

2

2. ACHC Health Analysis

2.1 Basic Checks

  • ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ACHC has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ACHC has more shares outstanding
  • ACHC has a worse debt/assets ratio than last year.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.07, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ACHC (1.07) is worse than 66.34% of its industry peers.
  • ACHC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • ACHC has a Debt to Equity ratio of 1.27. This is in the lower half of the industry: ACHC underperforms 64.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC0.76
WACC7.87%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that ACHC should not have too much problems paying its short term obligations.
  • ACHC's Current ratio of 1.55 is fine compared to the rest of the industry. ACHC outperforms 60.40% of its industry peers.
  • A Quick Ratio of 1.54 indicates that ACHC should not have too much problems paying its short term obligations.
  • ACHC has a Quick ratio of 1.54. This is in the better half of the industry: ACHC outperforms 64.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. ACHC Growth Analysis

3.1 Past

  • ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.79%.
  • ACHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.12% yearly.
  • ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.04%.
  • ACHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.65% yearly.
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.96% on average over the next years.
  • Based on estimates for the next years, ACHC will show a small growth in Revenue. The Revenue will grow by 6.26% on average per year.
EPS Next Y-25.62%
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%
EPS Next 5Y-1.96%
Revenue Next Year3.84%
Revenue Next 2Y4.9%
Revenue Next 3Y5.12%
Revenue Next 5Y6.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. ACHC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.64, the valuation of ACHC can be described as very reasonable.
  • ACHC's Price/Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 88.12% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ACHC to the average of the S&P500 Index (25.70), we can say ACHC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 15.65, ACHC is valued correctly.
  • Based on the Price/Forward Earnings ratio, ACHC is valued a bit cheaper than 74.26% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. ACHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 11.64
Fwd PE 15.65
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • ACHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACHC is cheaper than 79.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.98
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%

0

5. ACHC Dividend Analysis

5.1 Amount

  • ACHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACHC Fundamentals: All Metrics, Ratios and Statistics

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (3/13/2026, 8:08:38 PM)

After market: 23.37 -0.15 (-0.64%)

23.52

-0.62 (-2.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-11
Inst Owners133.62%
Inst Owner Change8.6%
Ins Owners1.24%
Ins Owner Change1.3%
Market Cap2.17B
Revenue(TTM)3.31B
Net Income(TTM)-1.10B
Analysts74
Price Target19.53 (-16.96%)
Short Float %35.92%
Short Ratio8.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.79%
Min EPS beat(2)5.25%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)12.66%
Min EPS beat(4)5.25%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)5.22%
EPS beat(12)10
Avg EPS beat(12)4.68%
EPS beat(16)13
Avg EPS beat(16)10.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)-1.83%
PT rev (3m)-11.26%
EPS NQ rev (1m)-21.95%
EPS NQ rev (3m)-28.77%
EPS NY rev (1m)-15.73%
EPS NY rev (3m)-33.55%
Revenue NQ rev (1m)1.6%
Revenue NQ rev (3m)1.19%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 11.64
Fwd PE 15.65
P/S 0.65
P/FCF N/A
P/OCF 16.44
P/B 1.11
P/tB 3.9
EV/EBITDA 7.98
EPS(TTM)2.02
EY8.59%
EPS(NY)1.5
Fwd EY6.39%
FCF(TTM)-4.77
FCFYN/A
OCF(TTM)1.43
OCFY6.08%
SpS35.93
BVpS21.14
TBVpS6.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.99
Profitability
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROCE 7.76%
ROIC 6%
ROICexc 6.16%
ROICexgc 8.63%
OM 11.71%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ROICexc(3y)7.58%
ROICexc(5y)7.53%
ROICexgc(3y)13.72%
ROICexgc(5y)14.49%
ROCE(3y)9.6%
ROCE(5y)9.52%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-7.02%
ROICexc growth 5Y2.87%
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 302.15%
Cap/Sales 17.26%
Interest Coverage 3.11
Cash Conversion 22.85%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 1.07
F-Score5
WACC7.87%
ROIC/WACC0.76
Cap/Depr(3y)361.37%
Cap/Depr(5y)312.98%
Cap/Sales(3y)17.88%
Cap/Sales(5y)15.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
EPS Next Y-25.62%
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%
EPS Next 5Y-1.96%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%
Revenue Next Year3.84%
Revenue Next 2Y4.9%
Revenue Next 3Y5.12%
Revenue Next 5Y6.26%
EBIT growth 1Y-25.72%
EBIT growth 3Y-4.55%
EBIT growth 5Y3.12%
EBIT Next Year46.21%
EBIT Next 3Y18%
EBIT Next 5Y20.08%
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.7%
OCF growth 3Y-29.76%
OCF growth 5Y-25.73%

ACADIA HEALTHCARE CO INC / ACHC Fundamental Analysis FAQ

What is the fundamental rating for ACHC stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACHC.


What is the valuation status for ACHC stock?

ChartMill assigns a valuation rating of 4 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.


Can you provide the profitability details for ACADIA HEALTHCARE CO INC?

ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ACADIA HEALTHCARE CO INC (ACHC) stock?

The Price/Earnings (PE) ratio for ACADIA HEALTHCARE CO INC (ACHC) is 11.64 and the Price/Book (PB) ratio is 1.11.


Can you provide the dividend sustainability for ACHC stock?

The dividend rating of ACADIA HEALTHCARE CO INC (ACHC) is 0 / 10 and the dividend payout ratio is 0%.